tiprankstipranks
Advertisement
Advertisement

VYNE Stock Latest News

Yarrow closes VYNE merger, initiates dosing in Phase 2a/2b YB-101 trial
The FlyYarrow closes VYNE merger, initiates dosing in Phase 2a/2b YB-101 trial
1M ago
VYNE
Upcoming Stock Splits This Week (July 27 to July 31) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (July 27 to July 31) – Stay Invested
1M ago
ZNB
AMZE
VYNE Therapeutics trading halted, news pending
PremiumThe Fly
VYNE Therapeutics trading halted, news pending
1M ago
VYNE
VYNE Therapeutics Announces Reverse Split and Merger Plans
PremiumCompany Announcements
VYNE Therapeutics Announces Reverse Split and Merger Plans
1M ago
8K
VYNE
VYNE Therapeutics announces 1-for-50 reverse stock split
PremiumThe Fly
VYNE Therapeutics announces 1-for-50 reverse stock split
1M ago
VYNE
VYNE Therapeutics advances reverse merger with Yarrow Bioscience
PremiumCompany AnnouncementsVYNE Therapeutics advances reverse merger with Yarrow Bioscience
1M ago
8K
VYNE
VYNE declares special dividend ahead of Yarrow merger
Premium
Company Announcements
VYNE declares special dividend ahead of Yarrow merger
2M ago
8K
VYNE
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
Premium
The Fly
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
2M ago
VYNE
VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
PremiumCompany Announcements
VYNE Highlights Yarrow Merger Strategy and Endocrine Pipeline
3M ago
8K
VYNE
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
PremiumCompany Announcements
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
6M ago
8K
VYNE
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
PremiumCompany Announcements
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
7M ago
8K
VYNE
3 Penny Stocks to Watch Now, 12/18/25
PremiumMarket News
3 Penny Stocks to Watch Now, 12/18/25
8M ago
BEAT
VYNE
Hold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
PremiumRatingsHold Rating for VYNE Therapeutics Amid Strategic Shift and Clinical Uncertainty Following Yarrow Bioscience Merger
8M ago
VYNE
VYNE Therapeutics Announces Merger with Yarrow Bioscience
Premium
Company Announcements
VYNE Therapeutics Announces Merger with Yarrow Bioscience
8M ago
8K
VYNE
VYNE Therapeutics, Yarrow Bioscience enter merger agreement
Premium
The Fly
VYNE Therapeutics, Yarrow Bioscience enter merger agreement
8M ago
VYNE
VYNE Therapeutics Approves Director Elections and Proposals
PremiumCompany Announcements
VYNE Therapeutics Approves Director Elections and Proposals
9M ago
8K
VYNE
VYNE Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
VYNE Therapeutics Reports Q3 2025 Financial Results
10M ago
VYNE
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
PremiumThe Fly
VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year
10M ago
VYNE
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
VYNE Therapeutics Faces Nasdaq Non-Compliance Notice
12M ago
8K
VYNE
VYNE Therapeutics Reports Q2 2025 Financials and Updates
PremiumCompany AnnouncementsVYNE Therapeutics Reports Q2 2025 Financials and Updates
1y ago
VYNE
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
Premium
Ratings
VYNE Therapeutics: Hold Rating Amid Mixed Clinical Outcomes and Financial Sustainability
1y ago
VYNE
VYNE Therapeutics Directors Resign Amid Financial Updates
Premium
Company Announcements
VYNE Therapeutics Directors Resign Amid Financial Updates
1y ago
8K
VYNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >